awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41633977-62E5B631-0C31-48EE-B8B7-F338522EE1BD
Q41633977-62E5B631-0C31-48EE-B8B7-F338522EE1BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41633977-62E5B631-0C31-48EE-B8B7-F338522EE1BD
Innovative treatments for severe refractory asthma: how to choose the right option for the right patient?
P2860
Q41633977-62E5B631-0C31-48EE-B8B7-F338522EE1BD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41633977-62E5B631-0C31-48EE-B8B7-F338522EE1BD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eb4fcca4d67bfaf5ae8f186c83e66325b6134bd2
P2860
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects.